Braxia Scientific (BRAX.C) CEO and Chief Medical Officer receive $918,000 grant to study ketamine assisted iCBT Post date July 28, 2021 Posted by Piers Eaton Posted in Biotech, brax.c, braxia, braxia scientific, CBT, CIHR, Cognitive Behavioral Therapy, CRTCE, Eaton, Government grant, Health Science, iCBT, IV, Psychedelics, Scribes Comments 0